Using a rocking bed to improve sleep in Parkinson's disease patients
Official title: Overnight Treatment of Parkinson's Disease Using Vestibular Stimulation From a Rocking Bed (Somnomat Casa) - A Feasibility Study
Run by Insel Gruppe AG, University Hospital Bern · NCT06386497 · Data updated 2026-11-12
This study is testing whether a special rocking bed can help improve sleep and overall well-being for people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Bern and 1 other locations) |
| Status | Recruiting |
| Started | January 11, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06386497 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with Parkinson's Disease who experience reduced sleep quality.
✕Probably not a fit
Patients with other brain diseases, severe psychiatric conditions, or those who are not fluent in German may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the feasibility and acceptability of using a rocking bed, known as Somnomat Casa, to provide nocturnal vestibular stimulation for patients with Parkinson's Disease over a two-month period. Twelve participants will receive this treatment in their home environment, and their feedback will be collected through questionnaires and interviews. The study will assess various outcomes, including sleep quality, motor and non-motor symptoms, and overall quality of life, using validated scales and physiological monitoring. Data will be collected before, during, and after the intervention to determine its effectiveness and acceptability.
Why it matters
Potential benefit: If successful, this intervention could significantly improve sleep quality and overall well-being for patients with Parkinson's Disease.
How similar studies have gone: While the approach of using vestibular stimulation for sleep improvement is novel, similar studies have shown promise in enhancing sleep quality in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed Consent signed by the subject * PD according to the MDS clinical diagnostic criteria for Parkinson's disease * Suffering from reduced sleep quality as defined by pathological cut-off (score of \> 5) on the Pittsburgh Sleep Quality Index (PSQI) * Patients with stable antiparkinsonian, antidepressant, and sleep medications for six weeks before intervention and maintained on stable medication during the intervention period * Treatment without bilateral deep brain stimulation * Fluent in German Exclusion Criteria: * Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.). * Dementia as defined by a MOCA score lower than 24/30 * Weight \> 150kg * Depression with acute suicidal ideation * Presence of major ongoing psychiatric illness such as acute non-controlled psychosis * Poor general health (e.g. non-controlled diabetes, uncontrolled arterial hypertension, therapy for malignancy) * Inability to follow the procedures of the study, e.g. filling out patient questionnaires due to language problems, psychological disorders, dementia, etc. of the participant * Participation in another interventional trial within the 30 days preceding and during the present study * Participants with PSQI score lower or equal 5
Where it's running
-
Insel Gruppe AG, University Hospital Bern
Bern, Switzerland Recruiting -
ETH Zurich, Sensory-Motor Systems Lab, IRIS
Zurich, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Lenard Lachenmayer, MD — Insel Gruppe AG, University Hospital Bern
- Study coordinator: Lenard Lachenmayer, MD
- Email: lenard.lachenmayer@insel.ch
- Phone: 31 66 4 12 59
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.